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Neurogenesis persists in the subgranular zone of the hippocampal formation in the adult 
mammalian brain. In this area, neural progenitor cells (NPCs) receive both permissive 
and instructive signals, including neurotransmitters, that allow them to generate adult-
born neurons which can be functionally integrated in the preexisting circuit. Deregulation 
of adult hippocampal neurogenesis (ahNG) occurs in several neuropsychiatric and 
neurodegenerative diseases, including major depression, and represents a potential 
therapeutic target. Of interest, several studies suggested that, both in rodents and 
in humans, ahNG is increased by chronic administration of classical monoaminergic 
antidepressant drugs, suggesting that modulation of this process may participate to their 
therapeutic effects. Since the established observation that noradrenergic innervations from 
locus coeruleus make contact with NPC in the dentate gyrus, we investigated the role of 
beta adrenergic receptor (β-AR) on ahNG both in vitro and in vivo. Here we report that, 
in vitro, activation of β2-AR by norepinephrine and β2-AR agonists promotes the formation 
of NPC-derived mature neurons, without affecting NPC survival or differentiation toward 
glial lineages. Additionally, we show that a selective β2-AR agonist able to cross the blood–
brain barrier, salmeterol, positively modulates hippocampal neuroplasticity when chronically 
administered in adult naïve mice. Indeed, salmeterol significantly increased number, maturation, 
and dendritic complexity of DCX+ neuroblasts. The increased number of DCX+ cells was not 
accompanied by a parallel increase in the percentage of BrdU+/DCX+ cells suggesting a 
potential prosurvival effect of the drug on neuroblasts. More importantly, compared to vehicle, 
salmeterol promoted ahNG, as demonstrated by an increase in the actual number of BrdU+/
NeuN+ cells and in the percentage of BrdU+/NeuN+ cells over the total number of newly 
generated cells. Interestingly, salmeterol proneurogenic effects were restricted to the ventral 
hippocampus, an area related to emotional behavior and mood regulation. Since salmeterol is 
commonly used for asthma therapy in the clinical setting, its novel pharmacological property 
deserves to be further exploited with a particular focus on drug potential to counteract 
stress-induced deregulation of ahNG and depressive-like behavior.
Keywords: adult neurogenesis, hippocampus, neural progenitor cells, beta adrenergic receptors, 
norepinephrine, doublecortin
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INTRODUCTION
Neurogenesis persists in discrete regions of adult mammalian 
brain. Among these regions, referred to as adult neurogenic niches, 
there is the subgranular zone (SGZ) in the dentate gyrus (DG) 
of the hippocampal formation (Ming and Song, 2011; Christian 
et al., 2014). In this area, adult hippocampal neurogenesis (ahNG) 
relies on the presence of neural progenitor cells (NPCs) which 
undergo proliferation and neuronal differentiation in response to 
instructive and permissive signals, including neurotransmitters 
(Eriksson et al., 1998, Spalding et al., 2013; Kempermann et al., 
2015). Through a complex and highly regulated process, adult-
born neuroblasts are generated and migrate to the granular cell 
layer (GCL) where they eventually mature into neurons which 
functionally integrate into the preexisting circuit (Markakis and 
Gage, 1999; Carlén et al., 2002; van Praag et al., 2002).
Although the physiological role of adult-born neurons is not 
fully understood, increasing experimental evidence suggests 
that they are involved in key hippocampal-dependent functions, 
such as learning, memory, and stress response (Snyder et al., 
2011; Gonçalves et al., 2016; Anacker and Hen, 2017; Toda and 
Gage, 2018). In line with the idea that it represents a peculiar 
form of neuroplasticity, ahNG is profoundly modulated by 
experience and environmental conditions. Positive modulators 
of ahNG are environmental enrichment, physical exercise, and 
learning (van Praag et al., 1999; Lee et al., 2002), while relevant 
negative modulators are aging, stress, and social isolation (Czéh 
et al., 2002; Lu et al., 2003; Westenbroek et al., 2004; Bortolotto 
et al., 2014).
Deregulation of adult neurogenesis has been demonstrated 
in several neurodegenerative disorders and in neuropsychiatric 
diseases (as recently reviewed by Peng and Bonaguidi, 2018; 
Toda et al., 2019). Major depression is one of the CNS disorders 
where ahNG has been more extensively investigated (Malberg 
and Duman, 2003; Vollmayr et al., 2007). Several studies 
indicate that chronic administration of classical monoaminergic 
antidepressant drug results in enhanced hippocampal 
neurogenesis in the adult human and rodent DG (Santarelli et al., 
2003; Boldrini et al., 2009; Perera et al., 2011; Surget et al., 2011; 
Boldrini et al., 2012), opening to the possibility that modulation 
of ahNG may contribute to the therapeutic effects of these drugs 
also in the clinical setting (Eisch and Petrik, 2012; Eliwa et al., 
2017; Sun et al., 2017). More generally speaking, these studies 
suggest that ahNG can be modulated pharmacologically, and this 
may have therapeutic relevance in several CNS disorders.
In the last decade, our laboratory has contributed to the 
identification of novel molecular regulators of ahNG with 
potential therapeutic relevance (Denis-Donini et al., 2008; 
Meneghini et al., 2013; Valente et al., 2015; Cvijetic et al., 2017; 
Cuccurazzu et al., 2018). Through these activities, we have been 
able to demonstrate that several drugs utilized in the clinical 
setting are endowed with the ability to promote ahNG in vitro 
and, more importantly, in vivo (Valente et al., 2012; Cuccurazzu 
et al., 2013; Meneghini et al., 2014; Chiechio et al., 2017). These 
accomplishments have allowed us to propose novel therapeutic 
indications for these drugs. On the other hand, they confirm the 
importance of increasing our current knowledge on drugs that 
are already in clinic to better understand not only their effects 
on adult NPC but also their full profile in terms of additional 
mechanisms of action and/or of potential side effects/tolerability 
issues (Bortolotto et al., 2014; Bortolotto and Grilli, 2017; 
Bortolotto et al., 2017; Grilli, 2017).
Since the established observations that the hippocampus 
receives dense noradrenergic innervations from the locus 
coeruleus (LC) (Sara et al., 1994; Kitchigina et al., 1997) and that 
noradrenergic afferents make direct contact with proliferating 
cells in adult DG (Rizk et al., 2006), we decided to deeply 
investigate the role of beta adrenergic receptor (β-AR)–mediated 
effects in the adult murine hippocampus in vitro and in vivo. 
Herein, we show that salmeterol, a β-AR agonist commonly 
utilized in asthma, is a proneurogenic molecule when chronically 
administered in adult naïve mice. Moreover, we propose that, 
at least in vitro, distinct β-AR subtypes may mediate different 
effects on adult hippocampal NPCs (ahNPCs).
MATERIALS AND METHODS
Animals. Male C57BL/6J mice were obtained from Jackson 
Laboratories. β2-AR−/− mice were kindly provided by Prof. Guido 
Iaccarino, Federico II University, Naples, Italy. Mice were housed 
in a light- and temperature-controlled room in high-efficiency 
particulate air (HEPA)-filtered Thoren units (Thoren Caging 
Systems) at the University of Piemonte Orientale animal facility. 
Mice were kept 3–4/cage with access to water and food ad libitum. 
Animal care and handling were performed in accordance with 
European Community Directive and approved by the local IACUC 
(Institutional Animal Care and Use Committees) Organismo 
Preposto al Benessere Animale (OPBA), Università del Piemonte 
Orientale, Novara, Italy. Only adult (3–6 months old) male mice 
were used for experimentation.
Drugs. The following drugs were utilized: L-(-)-
norepinephrine-(+)-bitartrate salt monohydrate (NE) purchased 
from Sigma–Aldrich (Milan, Italy), salmeterol xinafoate, 
formoterol hemifumarate, ICI118,551 hydrochloride, CGP20712 
dihydrochloride, SR59230A hydrochloride, and BRL37344 
sodium salt purchased from Tocris (Bioscience, Bristol, UK). In 
vitro drug concentrations were chosen based on Ki values at their 
target receptors.
Isolation and culture of adult hippocampal neural 
progenitor cells (ahNPCs). For preparing NPC primary cultures 
from hippocampi, three adult (3–4 months old) male mice were 
used, and cell suspension was prepared as previously described 
(Valente et al., 2012). Primary (passage 1, P1) neurospheres 
were dissociated after 7–10 days in vitro (DIV), whereas P2-P30 
neurospheres every five DIV. At each passage, cells were plated 
in T25 flask at a density of 12,000 cells/cm2 in complete culture 
medium consisting of neurobasal-A medium, supplemented with 
B27 supplement, 2 mM L-glutamine (Gibco, Life Technologies, 
Monza, IT), recombinant human epidermal growth factor 
(rhEGF, 20 ng/ml; PeproTech, Rock Hill, NJ), recombinant 
human fibroblast growth factor 2 (rhFGF-2, 10 ng/ml; PeproTech) 
and heparin sodium salt (4 µg/ml, Sigma–Aldrich), 100 U/ml 
penicillin, and 100 µg/ml streptomycin (Gibco).
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Neural progenitor cell proliferation, differentiation, 
and survival. ahNPC proliferation and differentiation were 
assessed as previously described (Bortolotto et al., 2017). 
Briefly, for proliferation assays, NPCs were seeded onto 
96-well plates (Falcon) at a 4,000 cells/well density in standard 
medium [STD medium: neurobasal-A, B27 supplement, 2 mM 
L-glutamine (Gibco), 10 ng/ml rhFGF-2 (PeproTech), 4 µg/ml 
heparin (Sigma–Aldrich), 100 U/ml penicillin, and 100 µg/ml 
streptomycin (Gibco)]. NPC were treated in the presence of the 
indicated drug concentrations or vehicle for 96 h. Proliferation 
medium with addition of rhEGF (20 ng/ml) was included as 
positive control. Proliferation rate was determined by CellTiter-
Glo luminescent cell viability assay (Promega), according to 
manufacturer’s instructions, and standard medium values were 
used to normalize obtained values. In differentiation assays, 
NPCs were plated onto laminin-coated (2.5 µg/cm2) Lab-Tek 
8-well Permanox chamber slides (NUNC) at the density of 43,750 
cells/cm2 in differentiation medium [neurobasal-A medium, B27 
supplement, 2 mM L-glutamine, and 100U/100 µg/ml penicillin/
streptomycin (Gibco)]. NPCs were differentiated for 24  h in 
presence of indicated concentration of drugs or vehicle. For 
β-AR blockade, cells were pretreated for 30  min with selective 
antagonists before addition of agonist drugs. The percentage 
of apoptotic NPCs was evaluated after counterstaining with 0.8 
ng/ml Hoechst (Thermo Fisher Scientific, Waltham, MA) diluted 
in PBS. Apoptotic nuclei were counted in drug- or vehicle-
treated cells using a fluorescence microscope DMIRB (Leica, 
Wetzlar, Germany) with a 60X objective (Meneghini et al., 2010). 
All in vitro experiments were run in triplicates using different cell 
preparations and repeated at least three times.
Immunocytochemical analysis. After 24 h of differentiation, 
ahNPCs were fixed by 4% paraformaldehyde/4% sucrose solution 
and processed for immunostaining as previously described 
(Meneghini et al., 2014). Primary antibodies were as follows: 
anti-nestin (chicken monoclonal, 1:1,500, Neuromics, Edina, 
MN), anti-microtubule-associated protein-2 (MAP-2, rabbit 
polyclonal, 1: 600, Millipore, Milan, Italy), anti-glial fibrillary 
acidic protein (GFAP, mouse polyclonal, 1:600, Millipore), and 
anti-chondroitin sulfate proteoglycan (NG-2, rabbit polyclonal, 
1:500, Millipore). Secondary antibodies were as follows: Alexa 
Fluor 488–conjugated goat anti-chicken (1:1,600), Alexa Fluor 
555–conjugated goat anti-rabbit (1:1,400), Alexa Fluor 555–
conjugated goat anti-mouse (1:1,600), and Alexa Fluor 488–
conjugated goat anti-rabbit (1:1,400) (all from Molecular Probes, 
Life Technologies). Nuclei were counterstained with 0.8 ng/ ml 
Hoechst (Thermo Fisher Scientific) diluted in PBS. In each 
experiment, five fields/well (corresponding to about 150–200 
cells/well) were counted using the fluorescence microscope 
DMIRB (Leica) with a 60X objective. Immunopositive cells for 
each marker were counted, and their percentage over total viable 
cells was calculated.
In vivo experiments. Adult male mice (4–6 month-old) were 
randomly distributed into vehicle and salmeterol treatment 
groups (n = 5/6). Vehicle (saline) and salmeterol (10 μg/kg body 
weight) were injected subcutaneously (s.c., 5 μl/g body weight) 
for a period of 21 days. During the first 5 days of the treatment, 
mice were also intraperitoneally (i.p.) injected once a day with 
bromodeoxyuridine (BrdU; 150 mg/kg body weight, 5 μl/g body 
weight, Sigma–Aldrich). Twenty-one days after the last BrdU 
injection, mice were deeply anesthetized and transcardially 
perfused with saline and then with paraformaldehyde 4% (PFA) 
in 0.1 M phosphate buffer, pH 7.4. After perfusion, brains were 
removed, postfixed in PFA 4% for 24 h, and then immersed in 
sucrose 30% for 24 h. In the end, brains were cut in 40 µm-thick 
coronal sections and stored in cryoprotectant solution at −20°C 
(Cuccurazzu et al., 2018).
Immunohistochemistry. For doublecortin (DCX) staining, 
procedure was as previously described (Dellarole and Grilli, 
2008). Briefly, sections were incubated with goat anti-DCX 
primary antibody (1:1,000, Santa Cruz Biotechnology, Santa 
Cruz, CA) followed by biotinylated horse anti-goat secondary 
antibody (1:200, Vector Laboratories, Burlingame, CA). Labeled 
cells were visualized using the ABC system (VECTASTAIN Elite, 
Vector Laboratories) with 3,3’-diaminobenzidine as chromogen, 
and sections were then counterstained with hematoxylin 
(Vector Laboratories). For triple immunostaining, the following 
antibodies were used: rat monoclonal anti-BrdU (1:200, Novus 
Biologicals Inc., Littleton, CO), goat anti-glial fibrillary acidic 
protein (GFAP, 1:100, Santa Cruz Biotechnologies), and mouse 
anti-neuronal nuclei (NeuN, 1:150, Millipore). For double 
DCX/BrdU immunostaining, the following antibodies were 
used: rat monoclonal anti-BrdU (1:200, Novus Biologicals Inc., 
Littleton, CO) and rabbit polyclonal anti-DCX (1:200, Cell 
Signaling Technology Inc., Beverly, MA).
Quantification and phenotypical characterization of 
newborn cells. A modified unbiased, stereological protocol was 
used for quantification and phenotypic characterization of cells, 
as previously described (Denis-Donini et al., 2008). Briefly, a 
complete series of one-in-eight brain sections throughout the 
DG was analyzed, and an average of 8–10 sections per animal 
was used. The SGZ was identified as corresponding to two cell 
bodies wide, along the border of the GCL. For DCX analysis, 
positive cells were quantified using a 60X objective along the 
rostrocaudal extension of DG. The total number of DCX+ cells 
was obtained by adding the number of labeled cells quantified 
from each section and multiplying them by 8. To determine the 
phenotype of BrdU+ cells, the DG of each section was scanned 
by using a LSM700 confocal laser-scanning microscope (Carl 
Zeiss, Le Pecq, France) and a 40X/1.3 objective with a 2 µm 
step size. To exclude a false double labeling resulting from the 
overlay of signals deriving from different cells, each BrdU+ cell 
was analyzed in its entire z-axis. The absolute number of BrdU+, 
BrdU+/NeuN+, and BrdU+/GFAP+ cells was quantified in the 
entire DG of each section, and then numbers were summed 
and multiplied by 8. For the dorsal and ventral DG analysis, the 
anatomical coordinates were selected according to The Mouse 
Brain Atlas (Paxinos and Franklin, 2004). In more details, 
coronal brain sections located from Bregma −0.94 to −2.46 mm 
were considered as corresponding to dorsal DG, while those 
located from Bregma −2.54 to −4.04 mm were considered as 
corresponding to ventral DG (Elizalde et al., 2010; Lehmann 
et al., 2013).
In a subset of vehicle- and salmeterol-treated animals 
(n  =  3/group), three brain sections were utilized for double 
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DCX/BrdU  immunostaining, as previously described 
(Meneghini et al., 2013), to evaluate the percentage of BrdU+ 
cells that had acquired a neuroblast phenotype.
Analysis of Dendritic Morphology. Dendritic arborization 
was evaluated for 70–80 DCX+ cells per mouse along the 
dorsal–ventral axis of DG. High-resolution stacks of images 
were obtained through a 20X/0.40 NA objective of an LSM700 
laser-scanning confocal microscope (Carl Zeiss) with 0.4-µm 
step size. Only DCX+ cells within the suprapyramidal blade of 
DG displaying an intact dendritic arborization reaching the 
molecular layer (ML) and without any overlaps with other cells 
or artifacts were selected and three dimensionally reconstructed 
using the simple neurite tracer plugin (Longair et al., 2011) on 
the image processing package Fiji (Schindelin et al., 2012). 3D 
reconstructions were exported as SWC files and analyzed with 
L-measure tool that allowed a quantitative characterization of 
neuronal morphology, evaluating a wide range of morphometrical 
parameters (Scorcioni et al., 2008).
Statistical analysis. Data were expressed as mean ± S.D. 
and analyzed using Student’s t-test when only two independent 
groups were compared, or by one-way analysis of variance 
(ANOVA) followed by Tukey’s post hoc test when three or more 
groups were compared. Statistical significance level was set for 
p values < 0.05. For the statistical analysis of morphological 
parameters, a linear mixed-effects model was applied to our 
dataset. The mixed-effects model takes into account that several 
measurements were obtained from the same animal and that 
these measurements are expected to be correlated among 
themselves. In order to overcome the dependency of the repeated 
measurements, a random animal effect has been included in 
the model. The presence of significant differences was tested 
using one-way ANOVA for each morphological parameter. The 
analysis was performed in R environment implemented with the 
lme4 package (Bates et al., 2015). Statistical significance level was 
set for p values < 0.05.
RESULTS
Norepinephrine (NE) Promotes Neuronal 
Differentiation of Adult Hippocampal 
Neural Progenitor Cells (ahNPCs)
Multipotent nestin+ and sox2+ NPCs isolated from adult mouse 
hippocampi can be maintained for several passages in an 
undifferentiated proliferative state (Cuccurazzu et al., 2013). Upon 
removal of growth factors followed by exposure to a serum-free 
defined medium, ahNPCs stop dividing and differentiating onto 
laminin-coated dishes. By double immunolabeling for markers 
of neurons (MAP-2) and undifferentiated progenitors (nestin), 
the appearance of newly generated MAP-2+/nestin− neurons can 
be evaluated and quantified as previously described (Meneghini 
et al., 2013). Under these experimental conditions, norepinephrine 
(0.1–10 µM; NE) treatment promoted a significant proneurogenic 
effect as demonstrated by an increase in the percentage of 
MAP-2+/nestin− cells (Figure 1A; p < 0.001 versus vehicle-
treated cells, ANOVA). In absence of growth factors, ahNPCs 
differentiate not only toward neuronal but also glial lineages. 
We assessed the percentage of newly generated astrocytes and 
oligodendrocyte precursors, GFAP+ and NG-2+ cells, respectively. 
Both populations were not affected by NE treatment as shown in 
Figure 1B, C (ANOVA). Finally, no significant difference in the 
percentage of apoptotic cells could be observed between vehicle- 
and NE-treated cells (Figure 1D; ANOVA). Altogether, these 
data confirm that, in vitro, NE promotes neuronal differentiation 
of ahNPCs in absence of changes in glial differentiation and 
survival rate.
NE Proneurogenic Effects Are Mediated 
by β2 and β3 Adrenergic Receptors
In order to pharmacologically characterize the proneurogenic 
effects induced by NE in our culture system, we exposed ahNPCs 
to the maximally effective concentration of NE (1 µM), after 
pretreatment with vehicle or ICI118,551 (100 nM), SR59230A 
(300 nM), and CGP20712 (10 nM) as selective β2-, β3-, and 
β1-AR antagonists, respectively. Both ICI118,551 and SR59230A 
antagonists prevented the increase in MAP-2+/nestin− cell 
percentage induced by NE (Figure 1E; p < 0.05 vs. NE-treated 
cells, ANOVA). Conversely, the β1-AR antagonist CGP20712 did 
not affect the proneurogenic effect of NE (Figure 1E; ANOVA). 
These data suggest that, in vitro, NE promotes neuronal 
differentiation of ahNPCs via β2- and β3-AR.
NE Proliferative Effects on ahNPCs Are 
Mediated by β1 Adrenergic Receptors
The above findings prompted us to investigate if distinct β-ARs 
may also differently modulate ahNPC proliferation. ahNPCs 
were seeded for 96  h in presence of NE (0.01–10 µM) and 
of ICI118,551 (100 nM), SR59230A (300 nM), CGP20712 
(10 nM) antagonists. As shown in Figure 2A, NE significantly 
promoted ahNPC proliferation compared to vehicle-treated 
cells (p < 0.001, ANOVA). CGP20712 significantly counteracted 
NE-mediated proliferation of ahNPCs (Figure 2B, p < 0.01 vs. 
NE-treated cells, ANOVA), while ICI118,551 and SR59230A 
were ineffective (Figure 2B; ANOVA). These findings suggest 
that NE exerts a positive effect on ahNPC proliferation through 
activation of β1-AR.
β2-Adrenergic Receptor Stimulation 
Promotes Neurogenesis In Vitro
Previous work in our laboratory proposed that tapentadol, an 
analgesic drug which has low affinity for the µ-opioid receptor, 
has no negative effects on ahNG because of its noradrenergic 
mechanism, and in particular via its ability to activate β2-AR 
(Meneghini et al., 2014). After confirmation of β2-AR mRNA 
expression in our cellular model (data not shown), we extended 
our investigation on the role of β2-AR in the promotion of 
neuronal differentiation. Thus, we treated ahNPCs with two 
selective long-acting β2-AR agonists, salmeterol and formoterol, 
which are commonly utilized in asthma. In presence of 
salmeterol (0.1–10 nM), we observed a significant increase in the 
percentage of MAP-2+/nestin− cells (Figures 3A, B, ANOVA). 
Similar effects were obtained in presence of formoterol 
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(0.01–10 nM; Figure 3C). Additionally, both salmeterol (0.3–
10 nM) and formoterol (0.1–10 nM) did not affect the percentage 
of newly generated GFAP+ and NG-2+ cells (Figures 3D, E; 
ANOVA). To confirm that salmeterol promotes neuronal 
differentiation of ahNPCs via activation of β2-AR, we pretreated 
cells with ICI118,551 (100 nM), SR59230A (300 nM), and 
CGP20712 (10 nM). As expected, only ICI118,551 completely 
prevented the proneurogenic effects induced by salmeterol 
(p < 0.001 versus salmeterol-treated cells, ANOVA), while 
SR59230A and CGP20712 had no effect (Figure 3F; ANOVA).
We also generated ahNPC cultures from β2-AR knockout 
(β2-AR−/−) mice. No difference was observed in the proliferation 
and differentiation rates of NPCs derived from β2-AR−/− versus 
ahNPCs derived from wild-type mice (data not shown). When 
β2-AR KO-derived ahNPCs were treated with salmeterol 
and formoterol, no proneurogenic effects were observed 
FIGURE 1 | Norepinephrine (NE) promotes neuronal differentiation and proliferation of ahNPCs via distinct receptor subtypes. Adult hippocampal NPCs were 
differentiated in presence of NE (0.1–10 µM) or vehicle (−) for 24 h. The percentages of MAP-2+/nestin− (A), GFAP+ (B), NG-2+ (C), and apoptotic (D) cells were 
evaluated. (E) Pharmacological characterization of β-ARs involved in NE-mediated effects on neuronal differentiation was performed by using selective receptor 
antagonists: ICI118,551 (ICI, β2-AR antagonist), SR59230A (SR, β3-AR antagonist), and CGP20712 (CGP, β1-AR antagonist). All experiments (n = 3) were run in 
triplicates. Data are expressed as mean ± S.D. **p < 0.01, ***p < 0.001 vs. vehicle-treated cells; #p < 0.05 versus NE-treated cells (one-way ANOVA, Tukey’s  
post hoc analysis).
FIGURE 2 | NE promotes ahNPC proliferation via β1-AR. (A) Evaluation of 96 h NE treatment on ahNPC proliferation. (B) Effects of ICI118,551, SR59230A, and 
CGP20712 on NE-mediated increase in ahNPC proliferation. Fold change compared to vehicle-treated ahNPCs (−). All experiments (n = 3) were run in triplicates. 
Data are expressed as mean ± S.D. **p < 0.01, ***p < 0.001, ****p < 0.0001 versus vehicle-treated cells; ##p < 0.01 versus 1 µM NE-treated cells (one-way ANOVA, 
Tukey’s post hoc analysis).
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(Figure 3G, ANOVA). As a control, the β3-AR agonist BRL37344 
could still promote neuronal differentiation of β2-AR KO 
(Figure 3G; ANOVA) and WT ahNPCs (data not shown). 
Altogether, these data confirmed that salmeterol and formoterol 
proneurogenic effects are mediated by engagement of β2-AR on 
adult hippocampal NPCs. Finally, we investigated the involvement 
FIGURE 3 | β2-AR agonists exert proneurogenic effects on ahNPCs. (A) Representative confocal images of MAP-2 (red) and nestin (green) immunolabeling in 
ahNPCs after 24 h treatment with vehicle (left panel) and 10 nM salmeterol (right panel). Nuclei were stained with DAPI (blue). MAP-2+/nestin− cells are indicated 
(arrowheads). Magnification 400X, scale bar = 20 µm. (B-C) Effects of β2-AR agonists salmeterol (0.1–10 nM) (B) and formoterol (0.01–10 nM) (C) on neuronal 
differentiation of ahNPCs. (D-E) Effects of 24-h treatment with salmeterol (SAL) and formoterol (FORM) on GFAP+ (D) and NG-2+ (E) cells. (F) Effect of 3 nM SAL 
in presence of vehicle, ICI118551, SR59230A, or CGP20712 antagonists. (G) Effects of 1 µM NE, 10 nM SAL, 10 nM FORM, and 100 nM BRL37344 (BRL) on 
neuronal differentiation of ahNPCs derived from β2-AR knockout mice. (H) Effects of salmeterol (0.0001–1 µM) on ahNPC proliferation. Fold change compared to 
vehicle-treated (−) ahNPCs. All experiments (n = 3) were run in triplicates. Data are expressed as mean ± S.D. **p < 0.01, ***p < 0.001 vs. vehicle-treated cells;  
###p < 0.001 vs. 3-nM SAL-treated cells (one-way ANOVA, Tukey’s post hoc analysis).
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of β2-AR in ahNPC proliferation. As shown in Figure 3H, 96 h 
treatment with salmeterol (0.0001–1 µM) did not change the 
proliferation rate of ahNPCs. Altogether, these data strongly 
corroborated the idea that stimulation of β2 adrenergic receptor 
results in neuronal differentiation of ahNPCs.
Effects of Chronic Salmeterol Treatment 
on Number, Orientation, and Dendritic 
Length/Complexity of Hippocampal  
DCX+ Neuroblasts
In order to understand whether chronic β2-AR stimulation 
had any effect on hippocampal plasticity in vivo, we performed 
a chronic treatment with the long-acting β2-AR agonist, 
salmeterol, which has been shown to cross the blood–brain 
barrier (Manchee et al., 1993). The choice of salmeterol was 
based on the in vivo potency of the drug (Qian et al., 2011). 
For such studies, adult male C57BL/6J mice (n = 5/6) received 
subcutaneous injections of vehicle (saline) or salmeterol 
(10 μg/kg) for 21 days. We initially focused our attention on newly 
born postmitotic neuroblasts which express the microtubule-
associated protein DCX (Dellarole and Grilli, 2008). We 
quantified the number of DCX immunolabelled cells (Figure 4A) 
in the DG. We observed a significant increase in the number 
of DCX+ cells of salmeterol – compared to vehicle-treated mice 
(Figure 4B; vehicle: 8.9 ± 1.6 × 103; salmeterol: 12.0 ± 1.6 × 103, 
p < 0.05, Student’s t-test). DCX+ neuroblasts can be subdivided in 
accordance with their cell body orientation, either tangential or 
radial, within the GCL. Neuroblasts characterized by tangential 
and radial orientation are proposed to be in an initial and 
advanced, respectively, stage of maturation (Brown et al., 2003). 
Interestingly, salmeterol significantly reduced the percentage of 
tangentially oriented DCX+ cells in GCL (Figure 4C; tangential 
DCX+: vehicle 53.6 ± 7.4%, salmeterol 39.3 ± 3.7%, p < 0.05, 
Student’s t-test) and, in parallel, induced a significant increase 
in the percentage of DCX+ cells with radially oriented cell 
FIGURE 4 | Chronic in vivo administration of salmeterol promotes significant changes in the number, orientation, and morphological complexity of DCX+ neuroblasts. 
(A) Representative photomicrographs of the DG of a mouse treated with vehicle (left panel) and salmeterol 10 µg/kg (right panel) and labeled with a DCX antibody. 
(Scale bar = 500 µm). The black rectangles indicate the area that is magnified as inset (scale bar = 50 µm). Higher magnification better identifies tangential (white 
arrowheads) and radial (black arrowheads) DCX+ cells in the granular cell layer. (B) Effect of salmeterol 10 µg/kg on the number of DCX+ cells in the DG. (C) Effects 
of salmeterol on the orientation of DCX+ cells in granular cell layer (GCL). Data are expressed as mean ± S.D.: *p < 0.05 vs. vehicle-treated mice (Student’s t-test). 
(D-E) Morphometrical analysis of DCX+ neuroblasts. Effects of 10 µg/kg salmeterol (SAL) on branch number (D) and on the arborization length (E) of DCX+ cells. 
Data are represented as Tukey box plots; outliers are represented by dots: *p < 0.05 vs. vehicle-treated mice (one-way ANOVA).
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bodies (Figure 4C; radial DCX+: vehicle 46.4 ± 7.4%, salmeterol 
60.7 ± 3.7%, p < 0.05, Student’s t-test). Altogether, these data 
corroborate the idea that in vivo stimulation of β2 adrenergic 
receptors results in neuroplasticity within the hippocampal DG, 
eliciting an increase in the number of neuroblasts and promoting 
their radial orientation.
To further investigate the effect of salmeterol on the maturation 
of neuroblasts, we also analyzed dendritic morphology and 
complexity in DCX+ cells. For each animal, 70–80 DCX+ cells 
were tridimensionally reconstructed and morphometrically 
characterized. Since we had multiple measurements made on 
multiple neurons per mouse, we used a mixed-effects approach to 
analyze morphometric data. By this choice, we could more accurately 
model our dataset in comparison to simple linear models. By 
morphometric analysis, we observed an overall increase of dendrite 
arborization induced by salmeterol. Indeed, in salmeterol-treated 
mice, DCX+ cells had a higher number of branches compared to 
vehicle-treated animals (Figure 4D; number of branches, vehicle: 
9.3 ± 0.43, salmeterol: 11.6 ± 0.42, p < 0.05, ANOVA). As shown 
in Figure 4E, the total length of dendritic arborizations was also 
increased by chronic drug treatment (vehicle: 276.2 ± 10.8 µm, 
salmeterol: 319.5 ± 12.5 µm, p < 0.05, ANOVA).
Chronic Salmeterol Administration Promotes 
Hippocampal Neurogenesis In Vivo
Despite changes in number, orientation and morphology of 
DCX+ neuroblasts in salmeterol-treated mice, a bonafide increase 
in adult hippocampal neurogenesis still needed to be rigorously 
addressed. Indeed, the increased number of neuroblasts in 
salmeterol-treated mice could also be due to drug-induced 
prosurvival effects. To this end, we took advantage of the fact 
that mice, chronically administered with salmeterol or vehicle, 
also received the thymidine analog BrdU (150 mg/kg of body 
weight, i.p.) during the first 5 days of treatment. The total number 
of BrdU+ cells was quantified in the DG of both vehicle- and 
salmeterol-treated mice, and no significant differences could 
be observed between the two groups (Figures 5A, B; vehicle: 
1.7 ± 0.3 X 103, salmeterol: 2.2 ± 0.4 X 103; p = 0.13, Student’s 
t-test). When we compared the number of BrdU+/NeuN+ 
cells, we observed a significant increase in mice treated with 
salmeterol compared with vehicle animals (Figure 5B; vehicle: 
1.4 ± 0.2 X 103, salmeterol: 2.0 ± 0.3 X 103; p < 0.05, Student’s 
t-test). We also calculated the percentage of BrdU+/NeuN+ cells 
over the total number of BrdU+ cells in the two experimental 
groups (Figure 5C). We confirmed an increased percentage 
FIGURE 5 | Chronic in vivo administration of salmeterol promotes neurogenesis in ventral hippocampus. (A) Representative confocal microscopic images of BrdU 
(blue), NeuN (red), immunolabeling in hippocampi of vehicle-treated (upper panel), and 10 µg/kg salmeterol-treated mice (lower panel). Single-positive BrdU cells 
(arrows) and BrdU+/NeuN+ cells (arrowheads) in the murine DG are indicated at 40X magnification (scale bar = 100 µm). (B) Quantitative analysis of BrdU+, BrdU+/
NeuN+, and BrdU+/GFAP+ cells in DG of vehicle- and 10 µg/kg salmeterol-treated mice. (C) Quantitative analysis of the percentage of newly generated neurons 
(BrdU+/NeuN+ cells) over total number of BrdU+ cells in DG of vehicle- and 10 µg/kg salmeterol-treated mice. (D) Quantitative analysis of BrdU+/NeuN+ cells in dorsal 
and ventral DG of vehicle- and 10 µg/kg salmeterol-treated mice. (E) Quantitative analysis of the percentage of BrdU+ cells that acquired DCX+ phenotype in DG of 
vehicle- and 10 µg/kg salmeterol-treated mice. Data are expressed as mean ± S.D.: *p < 0.05, **p < 0.01 vs. vehicle-treated mice (Student’s t-test).
Salmeterol Promotes Adult Hippocampal NeurogenesisBortolotto et al.
9 September 2019 | Volume 10 | Article 1000Frontiers in Pharmacology | www.frontiersin.org
of newly generated neurons in salmeterol mice (Figure 5C; % 
BrdU+NeuN+/BrdU+ cells: 79.4 ± 2.9 and 90.7 ± 4.9 in vehicle 
versus salmeterol-treated mice, respectively; p < 0.01, Student’s 
t-test). In agreement with in vitro data, no difference was 
observed in the number of BrdU+/GFAP+ cells between the two 
experimental groups (Figure 5B; vehicle: 26 ± 25.6, salmeterol: 
30 ± 7.6, Student’s t-test). Interestingly, when we examined 
dorsal and ventral hippocampi separately, we highlighted region-
specific effects elicited by salmeterol. In the ventral DG of drug-
treated mice, the number of BrdU+/NeuN+ cells was significantly 
increased compared to vehicle-treated group (Figure 5D; vehicle: 
602 ± 111.7, salmeterol: 1158 ± 380.2, p < 0.05; Student’s t-test). 
Conversely, no significant difference between vehicle- and drug-
treated mice could be observed in the dorsal DG (Figure 5D; 
vehicle: 816 ± 146.3, salmeterol: 854 ± 187.4; Student’s t-test.). 
Altogether, these data demonstrate that chronic salmeterol 
treatment promotes adult hippocampal neurogenesis in vivo, 
and, more specifically, in the ventral DG. In order to better 
understand the dynamic scenario occurring between neuroblasts 
and mature neuron formation in response to salmeterol, we also 
performed a double BrdU/DCX immunolabeling and calculated 
the percentage of hippocampal BrdU+ that had acquired a 
DCX+ phenotype. Surprisingly, we did not observe a significant 
difference between vehicle- and salmeterol-treated animals 
(Figure 5E; % BrdU+DCX+/BrdU+ cells: 43.7 ± 8.3 and 39.1 ± 
3.9 in vehicle versus drug-treated mice, respectively; p = 0.43, 
Student’s t-test). Since the overall number of BrdU+ cells is not 
statistically different between experimental groups, although 
there was a trend increase in drug- versus vehicle-treated mice, 
we hypothesize that the increase in the number of DCX+ cells 
observed in the salmeterol group could be due to an increased 
survival of hippocampal neuroblasts.
DISCUSSION
The SGZ of the hippocampal DG is one of the brain regions where 
generation of new neurons occurs throughout life (Altman and Das, 
1965; Cameron et al., 1993; Eriksson et al., 1998; Gould et al., 1998). 
In this region, adult NPCs proliferate and give rise to neuroblasts 
migrating to the GCL where they mature into neurons which may 
functionally integrate into the preexisting circuit (Markakis and 
Gage, 1999; Carlén et al., 2002; van Praag et al., 2002).
A vast array of signals affects and modulates ahNG, including 
neurotransmitter activity (Hagg, 2007; Toda et al., 2019). The 
dense monoaminergic innervation of the DG has attracted great 
interest for its contribution to adult neurogenesis modulation. 
At least in part, this is due to the fact that ahNG is proposed 
to underlie some of the behavioral effects elicited by classical 
antidepressants (Santarelli et al., 2003; Warner-Schmidt and 
Duman, 2006; Eliwa et al., 2017; Sun et al., 2017), whose actions 
are triggered by increased extracellular levels of serotonin and/or 
norepinephrine. Extensive research efforts have dissected the role 
of serotonin receptor subtypes in the regulation of ahNG both 
in vitro and in vivo (Alenina and Klempin, 2015; Bortolotto et al., 
2017). Comparatively, less is known about the role of adrenergic 
receptor subtypes in ahNG.
The noradrenergic transmission plays key regulatory roles 
in a variety of physiological processes, including specific 
aspects of learning and memory which have been functionally 
correlated with ahNG (Amaral and Sinnamon, 1977; Aston-
Jones and Cohen, 2005; Benarroch, 2009; Sara, 2009). Notably, 
the hippocampus is one of the brain areas receiving the densest 
noradrenergic innervation from LC (Swanson and Hartman, 
1975), and LC-derived noradrenergic afferents make direct 
contact with proliferating cells in adult DG (Rizk et al., 2006). 
In previous work, several groups have reported a permissive 
role for NE on adult hippocampal neurogenesis (Kulkarni 
et al., 2002; Jhaveri et al., 2010; Coradazzi et al., 2016). As far 
as receptor subtypes, while no major role of α1-AR has been 
proposed, α2-AR was initially suggested to be involved in 
the regulation of ahNG. Indeed, chronic treatment of rats 
with dexefaroxan, an α2-AR antagonist, promoted long-term 
survival of newborn hippocampal neurons by enhancing the 
number and complexity of the dendritic arborizations of PSA-
NCAM neurons, potentially via BDNF (Rizk et al., 2006). Less 
is known about the contribution of β-ARs, which are expressed 
in the hippocampus (Nicholas et al., 1993) and involved in 
learning and memory (Sara et al., 1994), in the modulation of 
hippocampal neurogenesis. Jhaveri et al., (2014) suggested that 
a balance between α2- and β-AR activity may regulate NPC 
activity and hippocampal  neurogenesis. They showed that 
selective stimulation of α2 adrenergic  receptors decreases NPC 
proliferation and immature neuron number, while stimulation of 
β adrenergic receptors activates the quiescent precursor pool and 
enhances their proliferation in the adult hippocampus. In their 
study, the authors used, as pharmacological tools, isoproterenol 
and propranolol as nonselective β-AR agonist and antagonist, 
respectively. Based on previous work showing that the β3-AR 
agonist BRL37344 had proliferative effects in the neurosphere 
assay (Jhaveri et al., 2010), the authors suggested that the 
in vitro effects of isoproterenol and NE could also be mediated 
by β3-ARs. On the other hand Masuda et al. (2012) by using 
adult rat NPCs suggested that NE pro-proliferative effects were 
mediated by β2-AR.
Based on these premises, we decided to further dissect the role 
of distinct β-AR in NE effects in adult hippocampal neurogenesis. 
By extensive pharmacological characterization, we initially 
proved that adult hippocampal NPCs functionally express 
β1/2/3-AR and that each receptor subtype exerts distinct effects 
when stimulated by NE, despite the fact that they all increase 
intracellular cAMP concentrations. We demonstrated that NE 
is able to significantly increase ahNPC proliferation in vitro and 
that this effect appears mediated by the β1-AR subtype. Indeed, 
a selective β1-AR antagonist completely inhibited NE-mediated 
NPC proliferation, while selective β2- and β3-AR antagonists were 
ineffective. Moreover, again by using selective antagonists, we 
demonstrated that β2/β3-AR activation–mediated NE effects on 
neuronal differentiation of ahNPCs. The contribution of β2-AR 
to neurogenesis was further confirmed by the fact that NE and 
the β2-AR agonists salmeterol and formoterol were ineffective 
in promoting neuronal differentiation of primary cultures of 
ahNPCs derived from β2-AR−/− mice. Interestingly, stimulation 
of β3-AR could still promote neurogenesis in β2-AR−/− NPC 
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cultures, confirming an additional role of this receptor subtype, 
as previously suggested (Jhaveri et al., 2010; Jhaveri et al., 2014).
These experimental observations prompted us to test clinically 
relevant β2-AR agonists, commonly utilized antiasthmatic drugs, 
as additional pharmacological tools for in vivo studies. Since not 
all β2-AR agonists cross the blood–brain barrier, for such studies, 
we selected salmeterol, a long-acting β2-AR. The drug, when 
administered subcutaneously for 21 days, was able to significantly 
promote neurogenesis in the adult murine hippocampus, as 
revealed by an increase in the number of BrdU+/NeuN+ newly 
generated neurons, as well as by a statistically significant increase 
in the percentage of BrdU+NeuN+/BrdU+ cells compared to 
vehicle-treated animals. In agreement with what we observed 
in vitro in adult hippocampal NPC cultures, salmeterol 
administration had no significant effect on astrogliogenesis in 
vivo, since no difference was reported in the number of BrdU+/
GFAP+ cells when compared with vehicle-treated mice. At least 
in vitro, we could exclude any effect of NE and β2-AR agonists 
not only on astrogliogenesis but also on the number of NG-2+ 
oligodendrocyte precursors which are generated by ahNPCs.
The proneurogenic effects of chronic salmeterol 
administration were accompanied also by a significant increase 
in the actual number of DCX+ cell in the DG of salmeterol-
treated mice. DCX is a microtubule-associated protein which is 
expressed by immature neurons in the adult DG and involved 
in cell migration (Corbo et al., 2002; Bai et al., 2003). For these 
reasons, DCX is commonly utilized as a marker of adult-born 
neuroblasts (Dellarole and Grilli, 2008). In parallel with the 
increased number of DCX+ cell in the DG of salmeterol-treated 
mice, we also observed a remarkable increase in the percentage 
of radially compared to tangentially oriented immunopositive 
cells. Interestingly, radial DCX+ cells are considered to represent 
a more advanced stage of maturation and migration compared to 
the ones which are tangentially oriented (Gleeson et al., 1999). 
Due to its distribution and pattern expression, DCX is also widely 
used for morphometric analysis of dendritic arborizations of 
adult-born neuroblasts (Kempermann et al., 2003). Our analysis 
revealed a significant positive effect of salmeterol administration 
on DCX+ dendritic complexity and length, compared to 
vehicle. Together with the changes in DCX+ cell orientation, 
our data suggested the idea that chronic salmeterol treatment 
increases hippocampal neuroplasticity by promoting DCX+ cell 
maturation. Surprisingly, when we quantified the percentage 
of hippocampal BrdU+DCX+/BrdU+ cells, we did not observe a 
significant difference between vehicle- and salmeterol-treated 
animals. Since the overall number of BrdU+ cells is not statistically 
different between groups, although there was a trend increase in 
drug- versus vehicle-treated mice, one potential explanation is 
that the increased number of DCX+ cells in the salmeterol group 
is due to increased survival of hippocampal neuroblasts. These 
findings are particularly interesting in view of the proposed 
heterogeneity within the DCX population (Walker et al., 2007) 
and previous reports that salmeterol may exert neuroprotective 
effects mediated by glial cells (Qian et al., 2011). Future studies 
will need to be properly designed to better understand the 
distinct effects of salmeterol administration on maturation and/
or survival of adult-born hippocampal neuroblasts and neurons. 
In vitro, we did not observe a prosurvival effect of β2-AR agonists 
on NPC neuronal progeny, so it is possible that salmeterol in vivo 
effects is mediated by cell populations which are underepresented 
or absent in culture.
Based on data in ahNPC cultures, salmeterol proneurogenic 
effects appear to be, at least in part, cell autonomous, while we 
cannot exclude the possibility that cell types other than ahNPCs 
may also contribute to drug-mediated proneurogenic and/
or prosurvival effects in vivo. Astrocytes indeed express β2-AR 
whose stimulation can mediate release of trophic factors which, 
in turn, may promote hippocampal neurogenesis (Laureys 
et al., 2010). Activation of AR on astrocytes may also affect 
neurogenesis indirectly, through neuronal metabolic support by 
astroglia. Indeed, astroglial aerobic glycolysis is regulated by NE 
through β-AR/cAMP signaling (Vardjan et al., 2014).
Interestingly, the proneurogenic effect of chronic salmeterol 
treatment was restricted to the ventral, but not the dorsal, region 
of the hippocampus. At the present stage, no literature data—
for example, different expression levels of β2-AR in ventral 
hippocampus (vHp) versus dorsal hippocampus (dHp), provide 
a clear explanation for region specificity in the proneurogenic 
effects of salmeterol, but they may deserve further investigation. 
Unfortunately, no reliable β2-AR antibodies are currently 
available. Despite these limitations, the finding of the region 
specificity of salmeterol is quite interesting since anatomical and 
functional segregation along the hippocampal dorso–ventral axis 
is a well established concept. The dHp mainly receives inputs from 
cortical areas, whereas the vHp is much more closely connected to 
subcortical structures, such as amygdala and the hypothalamic–
pituitary–adrenal axis (Grilli et al., 1988; Strange et al., 2014). 
In line with anatomical data, dHp appears to be preferentially 
involved in spatial navigation/memory and learning (Kim and 
Fanselow, 1992; Yoon and Otto, 2007; Fanselow and Dong, 2010), 
while the vHp has been connected with emotional reactivity and 
behavior (Pentkowski et al., 2006; Goodrich-Hunsaker et al., 
2008; McHugh et al., 2011). Worth of note, it has been suggested 
that dorsal and ventral ahNG may also be involved in different 
functions, with dorsal ahNG more correlated with cognitive 
functions while ventral ahNG with emotional behavior and mood 
regulation (Tanti and Belzung, 2013). In addition, external stimuli 
such as stress or drugs regulate adult neurogenesis differently along 
this axis. Previous reports have suggested that stress preferentially 
elicits deleterious effects on ventral hippocampal neurogenesis 
and that a decrease of ahNG in this area could be sufficient for 
the induction of depressive-like behavior (Felice et al., 2012; 
Hawley et al., 2012). Moreover, chronic treatment with different 
antidepressant drugs increased neurogenesis predominantly in 
vHp of rodents (Banasr et al., 2006; Wu and Hen, 2014; Zhou 
et al., 2016). This idea is further supported by studies in depressed 
patients showing prominent effects of selective serotonin reuptake 
inhibitors and tricyclic antidepressants in the anterior part of 
the hippocampus, the human correlate of rodent vHp (Boldrini 
et al., 2009, Boldrini et al., 2012). Interestingly, anatomical and 
biochemical evidence also support the idea that LC fibers in the 
fornix mainly innervate the dorsal DG while cingulum projects 
mainly to the ventral hippocampal formation where it supplies 
fibers to DG (Haring and Davis, 1985).
Salmeterol Promotes Adult Hippocampal NeurogenesisBortolotto et al.
11 September 2019 | Volume 10 | Article 1000Frontiers in Pharmacology | www.frontiersin.org
With the present work, we demonstrated hippocampal 
neuroplasticity and neurogenesis induced by chronic β2-AR agonist 
administration. The proneurogenic effects of salmeterol were 
restricted to the vHp. The behavioral correlates of these effects remain 
to be further investigated. Specifically, the effects of salmeterol in 
animal models of stress-induced depressive-like behavior could be 
investigated. Additionally, the possibility that β2-AR agonists that 
pass the blood–brain barrier may enhance antidepressant effects 
exists and could be tested. In light of the fact that a third of depressed 
patients do not satisfactorily respond or are resistant to antidepressant 
treatment, these observations certainly deserve further attention.
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